m
Recent Posts
Connect with:
Monday / May 23.
HomemiproductsTearScience: Now Part of Johnson and Johnson Vision

TearScience: Now Part of Johnson and Johnson Vision

The Johnson and Johnson Vision Solution for meibomian gland dysfunction (MGD) allows eye care professionals to effectively identify and treat MGD.

With 86 per cent of all dry eye being attributed to MGD, and 300 million dry eye sufferers worldwide, MGD patients represent one of the largest patient segments within eye care practices. MGD is prevalent, chronic, and progressive. By treating the root cause, eye care professionals intervene in the progression of the disease, improve gland function, and alleviate dry eye symptoms.

Contact: Johnson and Johnson Account Manager

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.